Annual Completed Clinical Trials Report

The growth of completed trials activity in 2023 reflects broad increases across most therapeutic areas, and a clear break from pandemic period fluctuations observed since 2020. In addition to broad-based completed trials growth in 2023, trial success rates improved year over year, another reflection of how the challenges of the pandemic years are no longer driving trends in 2023.